Raymond Yu
17Patents
5h-index
8Co-inventors
59Inventor score
Filing activity: Feb 7, 1997 → May 14, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5726629A | Lighting fixture with motion detector and announcement device | Emerging Cross-Sectional Technologies | 44 | Expired |
| US8946150B2 | Polypeptides that bound to IL-23 receptor and inhibit binding of IL-23 and cell signaling thereof | Human Necessities | 32 | Active |
| US9169292B2 | Polypeptides that bound to IL-23 receptor and inhibit binding of IL-23 and cell signaling thereof | Human Necessities | 32 | Active |
| US9210376B2 | Multimedia output and display device selection | Electricity | 27 | Active |
| US10372397B2 | Multimedia output and display device selection | Electricity | 11 | Active |
| US6418240B1 | Multiple frame image compression and decompression of motion video | Electricity | 5 | Expired |
| US9605027B2 | Polypeptides that bound to IL-23 receptor and inhibit binding of IL-23 and cell signaling thereof | Electricity | 4 | Active |
| US10366395B2 | Interactive and custom-support kiosk, methods and system | Physics | 1 | Active |
| USD846024S1 | Pen | General | 1 | Active |
| US9187750B2 | Anti-sense oligonucleotides targeted against exon 9 of IL-23Rα gene and method of using same to induce exon skipping and to treat inflammatory bowel diseases | Chemistry; Metallurgy | 0 | Active |
| US10416172B2 | Recombinant soluble truncated IL-23 receptor (IL-23R) capable of inhibiting IL-23R-mediated cell signaling | Physics | 0 | Active |
| US8618070B2 | Anti-sense oligonucleotides targeted against exon 9 of IL-23Rα gene and method of using same to induce exon skipping and to treat inflammatory bowel diseases | Chemistry; Metallurgy | 0 | Active |
| US9868776B2 | Anti-sense oligonucleotides targeted against exon 9 of IL-23R-alpha gene and method of using same to induce exon skipping and to treat inflammatory bowel diseases | Chemistry; Metallurgy | 0 | Active |
| US9523073B2 | Elisa for a naturally-occurring soluble truncated form of IL-23 receptor | Physics | 0 | Active |
| US8206925B2 | Splice variants of human IL-23 receptor (IL-23R) mRNA and use of a delta 9 isoform in predicting inflammatory bowel diseases | Chemistry; Metallurgy | 0 | Active |
| US8404824B2 | Splice variants of human IL-23 receptor (IL-23R) mRNA and use of a Δ9 isoform in predicting inflammatory bowel diseases | Chemistry; Metallurgy | 0 | Active |
| USRE49026E1 | Polypeptides that bound to IL-23 receptor and inhibit binding of IL-23 and cell signaling thereof | General | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.